|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1B
|
|
pubmed:dateCreated |
2006-6-2
|
|
pubmed:abstractText |
In breast cancer, the expression of CD24 represents a poorly recognised unfavourable prognostic factor. CD24 has been described to be potentially down-regulated by estrogen receptor alpha (ER). The present study was aimed at examining the predictive value of CD24 expression in tamoxifen-treated breast cancer cases.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
pubmed-author:DietelManfredM,
pubmed-author:KornafelJanJ,
pubmed-author:KristiansenGlenG,
pubmed-author:LageHermannH,
pubmed-author:MaciejczykAdamA,
pubmed-author:MaternaVerenaV,
pubmed-author:MatkowskiRafalR,
pubmed-author:PaluchowskiPiotrP,
pubmed-author:PudelkoMarekM,
pubmed-author:SurowiakPawelP,
pubmed-author:WojnarAndrzejA,
pubmed-author:ZabelMaciejM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
629-34
|
|
pubmed:meshHeading |
pubmed-meshheading:16739331-Antigens, CD24,
pubmed-meshheading:16739331-Antineoplastic Agents, Hormonal,
pubmed-meshheading:16739331-Breast Neoplasms,
pubmed-meshheading:16739331-Carcinoma, Ductal, Breast,
pubmed-meshheading:16739331-Drug Resistance, Neoplasm,
pubmed-meshheading:16739331-Female,
pubmed-meshheading:16739331-Humans,
pubmed-meshheading:16739331-Immunohistochemistry,
pubmed-meshheading:16739331-Middle Aged,
pubmed-meshheading:16739331-Predictive Value of Tests,
pubmed-meshheading:16739331-Receptors, Estrogen,
pubmed-meshheading:16739331-Tamoxifen,
pubmed-meshheading:16739331-Tumor Markers, Biological
|
|
pubmed:articleTitle |
CD24 expression is specific for tamoxifen-resistant ductal breast cancer cases.
|
|
pubmed:affiliation |
Institute of Pathology, Charité Campus Mitte, Berlin, Germany.
|
|
pubmed:publicationType |
Journal Article
|
